Ftse Mib
38.327,72
0,92%
DAX
22.798,09
1,40%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
96.056,49
0,29%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Clarivate PLC (CLVT) Clarivate PLC (CLVT) Notizie

Clarivate PLC

CLVT
4,86
-0,08 (-1,62%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/2/202515:30PRNUSClarivate Recognized for Excellence in Trademark Business in..
05/2/202509:00PRNUSClarivate Selected by National and University Library in..
04/2/202509:00PRNUSClarivate Reveals Medtech Breakthroughs Driving Growth in..
30/1/202509:00PRNUSClarivate identifies top 50 universities powering global..
28/1/202509:00PRNUSThe British Library Selects Clarivate to Provide Library..
22/1/202514:45PRNUSClarivate to Report Fourth Quarter and Full Year 2024..
16/1/202509:00PRNUSBioWorld by Clarivate Releases Comprehensive 2024 Year in..
14/1/202509:10PRNUSClarivate Launches DRG Fusion - A New Life Sciences..
08/1/202509:05PRNUSClarivate Identifies Eleven Potential Blockbuster and..
16/12/202423:00EDGAR2Form 8-K - Current report
16/12/202414:00PRNUSClarivate Announces New $500 Million Share Repurchase..
13/12/202423:00EDGAR2Form 8-K/A - Current report: [Amend]
12/12/202409:00PRNUSClarivate Launches AI-Powered Patent Search Solution in..
27/11/202414:00PRNUSClarivate and the Chinese Academy of Sciences Release Annual..
27/11/202409:00PRNUSDaikin Selects IPfolio from Clarivate
21/11/202409:00PRNUSBioWorld by Clarivate Highlights Gaps in Women's Health..
19/11/202409:00PRNUSClarivate Reveals Highly Cited Researchers 2024 List
18/11/202409:00PRNUSNew Report from Clarivate and Healthcare Executive Explores..
13/11/202409:00PRNUSClarivate Healthcare Business Insights Unveils 2023 Revenue..
12/11/202409:00PRNUSClarivate Publishes 2023 Sustainability Report
07/11/202409:00PRNUSClarivate Launches New Sustainability Research Solution
06/11/202412:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202412:02EDGAR2Form 8-K - Current report
06/11/202412:00PRNUSClarivate Reports Third Quarter 2024 Results
17/10/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202414:30PRNUSClarivate to Report Third Quarter 2024 Results on November..
15/10/202422:34EDGAR2Form 144 - Report of proposed sale of securities
15/10/202409:00PRNUSClarivate Repeats Success in Nobel Prize Predictions with..
04/10/202409:00PRNUSClarivate in partnership with Abiquifi Announces Annual..
25/9/202409:00PRNUSClarivate Unveils Comprehensive Framework to Evaluate the..
24/9/202409:00PRNUSNew Clarivate Report Reveals Challenges and Trends Shaping..
23/9/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202409:00PRNUSClarivate and Relatable Healthcare Forge Strategic..
19/9/202422:01EDGAR2Form 144 - Report of proposed sale of securities
19/9/202409:00PRNUSClarivate Reveals Citation Laureates 2024
18/9/202409:00PRNUSClarivate Announces 15th Annual Pharmavision India..
09/9/202409:00PRNUSClarivate Report Unveils the Transformative Role of..
05/9/202415:00PRNUSClarivate to Present at the Goldman Sachs Communacopia +..
04/9/202409:00PRNUSClarivate Launches Generative AI-Powered Web of Science..
30/8/202423:05EDGAR2Form 144 - Report of proposed sale of securities
20/8/202409:00PRNUSClarivate Names Melanie Margolin as Chief Administrative and..
16/8/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/8/202414:15PRNUSClarivate to Present at the Oppenheimer 27th Annual..
06/8/202422:46EDGAR2Form 8-K - Current report
Apertura: 4,97 Min: 4,88 Max: 5,01
Chiusura: 4,94

La tua Cronologia

NYSE
CLVT
Clarivate
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci